title: Pharmaceuticals. Pfizer's shakeup means less money for research.
authors.forename: Sam
authors.initials: S
authors.lastname: Kean
mesh_terms: D035843:Biomedical Research / Q000191:economics*; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration; D000078329:Workforce